Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2Venous Thromboembolism 1Thrombosis 1Obesity 1Neoplasms 1Colorectal Neoplasms, Hereditary Nonpolyposis 1Colorectal Neoplasms 1Colorectal Neoplasia 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Tirzepatide 2Metformin 2Hydrocortisone 2Ovidrel 1Leuprolide 1Dexamethasone 1Cosyntropin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Obesity × Aspirin × Clear all
NCT02062255 2016-10-26

Impact of COX2 on Sera Biomarkers From Obese Subjects

The University of Texas Health Science Center at San Antonio

Phase EARLY_PHASE1 Completed
126 enrolled
Other

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡